MB49 In Vitro Telomere Length Analysis Assay (Senescence)
CAT#: ITS-1022-YF3301
Target Cell Organism: Mouse
Target Cell Name: MB49
Assay Type: Cellular Senescence in Cancer Assays
Assay Overview
This assay is to provide MB49-based In Vitro Telomere Length Analysis Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
MB49
Target Cell Organism
Mouse
Target Cell Background
MB49 cells are derived from C57BL/Icrf-a' mouse bladder epithelial cells that were transformed by a single 24-hour treatment with the chemical carcinogen 7, 12-dimethylbenz[a]anthracene (DMBA) on the second day of a long term primary culture. Transformed cells transplanted into syngeneic mice were shown to generate carcinomas. While of male origin, karyotype analyses indicate the loss of the Y chromosome in 100% of the cells analyzed. This abnormality is a frequent early event in human bladder cancer.
Related Diseases
Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro Telomere Length Analysis Assay (Senescence)
Short Description
MB49-cell based In Vitro Telomere Length Analysis Assay (Senescence)
Assay Description
For the analysis of telomere length, terminal restriction fragment analysis technique has been the commonly used technique for a long time.
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.